+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Health Technology Assessment"

Acellular Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Acellular Therapy Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 183 Pages
  • Global
From
FIC Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

FIC Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 196 Pages
  • Global
From
Specialty Pharmaceuticals Market - Global Forecast 2026-2032 - Product Thumbnail Image

Specialty Pharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 190 Pages
  • Global
From
C1-INH Replacement Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

C1-INH Replacement Therapy Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 189 Pages
  • Global
From
Drugs for PNH Market - Global Forecast 2026-2032 - Product Thumbnail Image

Drugs for PNH Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 196 Pages
  • Global
From
Drugs for PrEP Market - Global Forecast 2026-2032 - Product Thumbnail Image

Drugs for PrEP Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 183 Pages
  • Global
From
GalNAc-based Drug Market - Global Forecast 2026-2032 - Product Thumbnail Image

GalNAc-based Drug Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 186 Pages
  • Global
From
PPMO Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

PPMO Therapy Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 192 Pages
  • Global
From
Anti-amyloid Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Anti-amyloid Therapy Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 181 Pages
  • Global
From
Anti-amyloid Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Anti-amyloid Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 197 Pages
  • Global
From
From
Oral Peptide Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Oral Peptide Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 196 Pages
  • Global
From
From
Yemugua Pian Market - Global Forecast 2025-2030 - Product Thumbnail Image

Yemugua Pian Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
Xiaoqinglong Granules Market - Global Forecast 2025-2030 - Product Thumbnail Image

Xiaoqinglong Granules Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 190 Pages
  • Global
From
PMO Drug Market - Global Forecast 2025-2030 - Product Thumbnail Image

PMO Drug Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 180 Pages
  • Global
From
Pimavanserin Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Pimavanserin Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
From
Oral Anti-HBV Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Oral Anti-HBV Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
From
Loading Indicator

The Health Technology Assessment (HTA) market within the context of Pharmaceuticals is a rapidly growing industry. It is a process of evaluating the clinical, economic, and social impact of a medical technology, such as a drug, device, or procedure. HTA is used to inform decision-making in healthcare, such as reimbursement decisions, and to ensure that healthcare resources are used in the most effective and efficient way. HTA is conducted by independent organizations, such as government agencies, research institutes, and private companies. HTA is becoming increasingly important in the pharmaceutical industry, as it helps to ensure that new drugs are safe and effective, and that they provide value for money. HTA also helps to ensure that new drugs are used appropriately, and that they are targeted to the right patients. Some companies in the HTA market include IQVIA, Parexel, Syneos Health, and Evidera. Show Less Read more